封面
市场调查报告书
商品编码
1842098

北美氧气浓缩机市场:市场规模、份额、趋势分析(按产品、应用、技术和国家划分)、细分市场预测(2025-2033 年)

North America Oxygen Concentrators Market Size, Share & Trends Analysis Report By Product (Portable Oxygen Concentrator, Fixed Oxygen Concentrator), By Application (Home Care, Non-home Care), By Technology, By Country, And Segment Forecasts, 2025 - 2033

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

北美氧气浓缩机市场摘要

北美氧气浓缩机市场预计在 2024 年达到 19.9 亿美元,预计到 2033 年将达到 47.2 亿美元,2025 年至 2033 年的复合年增长率为 10.0%。

这种增长是由慢性阻塞性肺病、气喘和睡眠呼吸中止症等呼吸系统疾病的日益普遍所驱动的。

根据加拿大气喘协会2024年的全国调查,加拿大有超过460万人患有气喘,其中包括90万名19岁以下的儿童和80万名65岁以上的成年人。气喘是加拿大第三常见慢性疾病,估计每天新增病例317例,每年约有250人死于气喘。呼吸技术的进步也大大推动了气喘市场的成长。

此外,优惠的报销政策也使北美氧气浓缩机市场更具吸引力。例如,2024年3月,美国众议院提出了《补充氧气取得改革法案》(SOAR),旨在改革和改善联邦医疗保险受益人获得补充氧气的​​途径。这项政策正在加速氧气浓缩机在美国的普及。此外,美国和加拿大不断上涨的医疗保健成本也推动了对呼吸系统疾病有效诊断和治疗的需求,从而促进了氧气浓缩机市场的发展。

世界卫生组织(WHO)分发氧气浓缩机以及美国肺臟协会等机构的努力等公共和私人倡议,正在提高公众对呼吸系统疾病的认识。市场参与者也采取收购、合作、业务扩张和推出新产品等策略,以扩大其产品范围和地理覆盖率。例如,2025年6月,Inogen推出了Voxi 5固定式氧气浓缩机,为美国长期照护患者提供经济实惠、经久耐用且静音的连续流氧气疗法解决方案,提高了居家呼吸照护的可近性。该设备设计紧凑,配有便于移动的脚轮,提供三年筛网床保修,并采用先进的过滤技术。

目录

第一章 分析方法和范围

第二章执行摘要

第三章 市场因素、趋势与范围

  • 市场关联性展望
  • 市场动态
    • 市场驱动因素分析
    • 慢性阻塞性肺病、气喘和睡眠呼吸中止症等呼吸系统疾病的盛行率不断上升。
    • 扩大居家医疗的引入
    • 氧气浓缩机的技术进步
    • 推出新世代产品并拓展业务
  • 市场限制因素分析
  • 氧气浓缩机的高成本
    • 产业机会分析
    • 产业问题分析
    • 案例研究
  • 商业环境分析
    • 波特五力分析
    • 供应商电力
    • 买方力量
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争对手之间的竞争
  • PESTLE分析
    • 政局
    • 经济和社会状况
    • 技术格局
    • 环境状况
    • 法律状况

第四章 北美氧气浓缩机市场:按产品分類的估算与趋势分析

  • 产品仪錶板
  • 市占率及波动分析:依产品划分(2024 年及 2033 年)
  • 按产品分類的市场规模预测和趋势分析(2021-2033)
  • 可携式医用氧气浓缩机
  • 固定式医用氧气浓缩机

第五章 北美氧气浓缩机市场:按应用分類的估算和趋势分析

  • 特定用途的仪錶板
  • 市占率及波动分析:依应用领域划分(2024 年及 2033 年)
  • 按应用领域分類的市场规模预测和趋势分析(2021-2033)
  • 居家医疗
  • 除了居家医疗之外

第六章 北美氧气浓缩机市场:依技术分類的估算与趋势分析

  • 技术仪錶板
  • 市占率及波动分析:依技术划分(2024 年及 2033 年)
  • 按技术分類的市场规模预测和趋势分析(2021-2033)
  • 连续流
  • 脉动电流

第七章 北美氧气浓缩机市场:各国估算与趋势分析

  • 各国市场:仪錶板
  • 各国市场:主要结论
    • 美国
    • 加拿大
    • 墨西哥

第八章 竞争情势

  • 参与者概览
  • 按产品分類的公司市占率分析(2021-2024)
    • 可携式医用氧气浓缩机市场份额
    • 固定式医用氧气浓缩机的市场份额
  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • Respironics(a subsidiary of Koninklijke Philips NV){Effective from January 25, 2024, Philips Respironics halted the sale of their POCs, with end of service scheduled for January 25, 2029.}
    • Direct Supply
    • GF Health Products, Inc.
    • MedaCure Inc.
    • Nidek Medical Products, Inc
    • O2 Concepts
    • React Health
    • CAIRE Inc.(Acquired by Niterra Co., Ltd. formerly known as NGK SPARK PLUG CO., LTD.)
    • DeVilbiss Healthcare(a subsidiary of Drive Medical)
    • GCE Group
    • Compass Health Brands
Product Code: GVR-4-68039-367-3

North America Oxygen Concentrators Market Summary

The North America oxygen concentrators market size was estimated at USD 1.99 billion in 2024 and is projected to reach USD 4.72 billion by 2033, growing at a CAGR of 10.0% from 2025 to 2033. The growth is attributed to an increase in the prevalence of respiratory conditions such as COPD, asthma, and sleep apnea.

According to the 2024 National Survey by Asthma Canada, over 4.6 million people in Canada are living with asthma, including 900,000 children under 19 and 800,000 adults over 65. Asthma is the third most prevalent chronic disease in the country, with an estimated 317 new diagnoses every day and around 250 deaths annually. In addition, advancements in respiratory technology are significantly supporting market growth.

Furthermore, favorable reimbursement policies have enhanced the attractiveness of the oxygen concentrators market in North America. For instance, in March 2024, a U.S. Congressman introduced the Supplemental Oxygen Access Reform (SOAR) Act to reform and improve access to supplementary oxygen for Medicare beneficiaries. These policies have increased the adoption of oxygen concentrators in the U.S. In addition, rising healthcare spending in the U.S. and Canada is driving the demand for effective diagnosis and treatment of respiratory diseases, thereby boosting the market for oxygen concentrators.

Initiatives by public and private authorities, such as the World Health Organization's distribution of oxygen concentrators and the efforts of associations like the American Lung Association, promote awareness of respiratory diseases. Market players also employ strategies such as acquisitions, collaborations, expansions, and new product launches to extend their product offerings and geographical reach. For instance, in June 2025, Inogen launched the Voxi 5 stationary oxygen concentrator, offering an affordable, durable, and quiet continuous flow oxygen therapy solution for long-term care patients in the US, enhancing home respiratory care accessibility. The device features a compact design, caster wheels for mobility, a 3-year sieve bed warranty, and advanced filtration technology.

North America Oxygen Concentrator Market Report Segmentation

This report forecasts volume & revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America oxygen concentrator market report on the basis of product, application, technology, and country.

  • Products Outlook (Volume, Unit 000'; Revenue, USD Million, 2021 - 2033)
  • Portable Medical Oxygen Concentrators
  • Fixed Medical Oxygen Concentrators
  • Application Outlook (Volume, Unit 000'; Revenue, USD Million, 2021 - 2033)
  • Home Care
  • Non-home Care
  • Technology Outlook (Volume, Unit 000'; Revenue, USD Million, 2021 - 2033)
  • Continuous Flow
  • Pulse Flow
  • Country Outlook (Volume, Unit 000'; Revenue, USD Million, 2021 - 2033)
  • U.S
  • Canada
  • Mexico

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Products
    • 1.2.2. Application
    • 1.2.3. Technology
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Increase in the prevalence of respiratory conditions such as COPD, asthma, and sleep apnea.
    • 3.2.3. Growing adoption of home healthcare
    • 3.2.4. Technological advancements in oxygen concentrators
    • 3.2.5. Launch of new generation products and increasing business expansion
  • 3.3. Market Restraint Analysis
  • 3.4. High cost associated with oxygen concentrators
    • 3.4.1. Industry Opportunity Analysis
    • 3.4.2. Industry Challenge Analysis
    • 3.4.3. Case Studies
  • 3.5. Business Environment Analysis
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. Supplier power
    • 3.5.3. Buyer power
    • 3.5.4. Substitution threat
    • 3.5.5. Threat of new entrant
    • 3.5.6. Competitive rivalry
  • 3.6. PESTLE Analysis
    • 3.6.1. Political landscape
    • 3.6.2. Economic and Social landscape
    • 3.6.3. Technological landscape
    • 3.6.4. Environmental landscape
    • 3.6.5. Legal Landscape

Chapter 4. North America Oxygen Concentrator Systems Market: Products Estimates & Trend Analysis

  • 4.1. Products Segment Dashboard
  • 4.2. Products Market Share Movement Analysis, 2024 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Products, 2021 to 2033 (USD Million, Unit Volume 000')
  • 4.4. Portable Medical Oxygen Concentrators
    • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 4.4.2. Market estimates and forecast 2021 to 2033 (Unit Volume 000')
  • 4.5. Fixed Medical Oxygen Concentrators
    • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 4.5.2. Market estimates and forecast 2021 to 2033 (Unit Volume 000')

Chapter 5. North America Oxygen Concentrator Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Application Market Share Movement Analysis, 2024 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Home Care
    • 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5. Non-Home Care
    • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. North America Oxygen Concentrator Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Segment Dashboard
  • 6.2. Technology Market Share Movement Analysis, 2024 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 6.4. Continuous flow
    • 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.5. Pulse Flow
    • 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. North America Oxygen Concentrator Market: Country Estimates & Trend Analysis

  • 7.1. Country Market Dashboard
  • 7.2. Country Market: Key Takeaways
    • 7.2.1. U.S.
      • 7.2.1.1. Key country dynamic
      • 7.2.1.2. Regulatory framework
      • 7.2.1.3. Competitive insights
      • 7.2.1.4. North America Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.2.2. Canada
      • 7.2.2.1. Key country dynamic
      • 7.2.2.2. Regulatory framework
      • 7.2.2.3. Competitive insights
      • 7.2.2.4. Canada Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.2.3. Mexico
      • 7.2.3.1. Key country dynamic
      • 7.2.3.2. Regulatory framework
      • 7.2.3.3. Competitive insights
      • 7.2.3.1. Mexico Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Share Analysis (2021-2024), by product
    • 8.2.1. Company Market share for Portable Medical Oxygen Concentrators
    • 8.2.2. Company Market share for Fixed Medical Oxygen Concentrators
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Respironics (a subsidiary of Koninklijke Philips N.V.) {Effective from January 25, 2024, Philips Respironics halted the sale of their POCs, with end of service scheduled for January 25, 2029.}
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Products benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. Direct Supply
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Products benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. GF Health Products, Inc.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Products benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. MedaCure Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Products benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Nidek Medical Products, Inc
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Products benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. O2 Concepts
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Products benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. React Health
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Products benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. CAIRE Inc. (Acquired by Niterra Co., Ltd. formerly known as NGK SPARK PLUG CO., LTD.)
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Products benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. DeVilbiss Healthcare (a subsidiary of Drive Medical)
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Products benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. GCE Group
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Products benchmarking
    • 8.5.11. Compass Health Brands
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Products benchmarking

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America Oxygen concentrator market , products, 2021 - 2033 (USD Million)
  • Table 4 North America Oxygen concentrator market , products, 2021 - 2033 (Unit Volume 000')
  • Table 5 North America Oxygen concentrator market , by application, 2021 - 2033 (USD Million)
  • Table 6 North America Oxygen concentrator market , by technology, 2021 - 2033 (USD Million)
  • Table 7 U.S. Oxygen concentrator market , products, 2021 - 2033 (USD Million)
  • Table 8 U.S. Oxygen concentrator market , products, 2021 - 2033 (Unit Volume 000')
  • Table 9 U.S. Oxygen concentrator market , by application, 2021 - 2033 (USD Million)
  • Table 10 U.S. Oxygen concentrator market , by technology, 2021 - 2033 (USD Million)
  • Table 11 Canada Oxygen concentrator market , products, 2021 - 2033 (USD Million)
  • Table 12 Canada Oxygen concentrator market , products, 2021 - 2033 (Unit Volume 000')
  • Table 13 Canada Oxygen concentrator market , by application, 2021 - 2033 (USD Million)
  • Table 14 Canada Oxygen concentrator market , by technology, 2021 - 2033 (USD Million)
  • Table 15 Mexico Oxygen concentrator market , products, 2021 - 2033 (USD Million)
  • Table 16 Mexico Oxygen concentrator market , products, 2021 - 2033 (Unit Volume 000')
  • Table 17 Mexico Oxygen concentrator market , by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico Oxygen concentrator market , by technology, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 North America oxygen concentrator Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market formulation & validation
  • Fig. 6 Market research approaches
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD modelling for market share assessment
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Market snapshot
  • Fig. 11 Market segmentation (USD Million)
  • Fig. 12 Competitive landscape
  • Fig. 13 Parent market outlook (In USD Million)
  • Fig. 14 Related/ancillary market outlook (In USD Mllion)
  • Fig. 15 North America oxygen concentrator market dynamics
  • Fig. 16 North America oxygen concentrator market: Porter's five forces analysis
  • Fig. 17 North America oxygen concentrator market: PESTLE analysis
  • Fig. 18 North America oxygen concentrator market: Products segment dashboard
  • Fig. 19 North America oxygen concentrator market: Products market share analysis, 2024 & 2033
  • Fig. 20 Portable medical oxygen concentrators market, 2021 - 2033 (USD Million)
  • Fig. 21 Portable medical oxygen concentrators market, 2021 - 2033 (Unit Volume 000')
  • Fig. 22 Fixed medical oxygen concentrators market, 2021 - 2033 (USD Million)
  • Fig. 23 Fixed medical oxygen concentrators market, 2021 - 2033 (Unit Volume 000')
  • Fig. 24 North America oxygen concentrator market: Application dashboard
  • Fig. 25 North America oxygen concentrator market: Application market share analysis, 2024 & 2033
  • Fig. 26 Home care market, 2021 - 2033 (USD Million)
  • Fig. 27 Non-home care market, 2021 - 2033 (USD Million)
  • Fig. 28 North America oxygen concentrator market: Technology segment dashboard
  • Fig. 29 Continous flow market, 2021 - 2033 (USD Million)
  • Fig. 30 Pluse flow market, 2021 - 2033 (USD Million)
  • Fig. 31 North America oxygen concentrator market revenue, by Country
  • Fig. 32 Country marketplace: Key takeaways
  • Fig. 33 U.S. oxygen concentrator market, 2021 - 2033 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 Canada oxygen concentrator market, 2021 - 2033 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 Mexico oxygen concentrator market, 2021 - 2033 (USD Million)
  • Fig. 38 Company categorization
  • Fig. 39 Company market share analysis (2024)
  • Fig. 40 Strategic framework